Cheng Tang

机构：Jiangsu Province Hospital, Nanjing Medical University · ORCID：0000-0002-5876-0315

发表论文 58 篇 · 总被引 897 次 · h-index 19

代表论文

• The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction (2022 · Nature Communications · 被引 86)
• HMGA1B/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12/CXCR4 axis-mediated macrophage polarization (2021 · Cell Death and Disease · 被引 61)
• Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer (2022 · Journal of Experimental & Clinical Cancer Research · 被引 51)
• Manual therapy regulates oxidative stress in aging rat lumbar intervertebral discs through the SIRT1/FOXO1 pathway (2022 · Aging · 被引 30)
• Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver Fibrosis (2021 · Frontiers in Pharmacology · 被引 29)
• miR-144-3p inhibited the growth, metastasis and epithelial-mesenchymal transition of colorectal adenocarcinoma by targeting ZEB1/2 (2021 · Aging · 被引 23)